Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.940
+0.8208.10%
Volume:8.78M
Turnover:94.26M
Market Cap:4.45B
PE:-12.32
High:11.060
Open:10.120
Low:10.080
Close:10.120
52wk High:246.000
52wk Low:9.010
Shares:407.00M
HK Float Shares:312.00M
Volume Ratio:2.09
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.888
ROE:-36.78%
ROA:-20.32%
PB:4.34
PE(LYR):-12.32
PS:107.52

Loading ...

TransThera Wins China Marketing Approval for Bile Duct Cancer Drug

MT Newswires Live
·
Aug 07

Movement Alert|TRANSTHERA-B Rises 21.51% in Regular Trading, Core Drug Tinengotinib Receives NMPA Conditional Approval

Market Focus
·
Aug 07

Transthera-B secures NMPA approval for Je'ente in advanced bile duct cancer treatment

Stock News
·
Aug 06

Transthera Sciences (Nanjing) - Nmpa Grants Marketing Approval for Yochanra (Tinengotinib Tablets)

THOMSON REUTERS
·
Aug 06

Genecare Development Reduces Stake in TRANSTHERA-B, Sells 467,500 Shares at Approximately HK$12.58 Each

Stock News
·
Aug 06

TRANSTHERA-B: Morningside Venture (I) Investments Limited Sees Disposal of Shares, Long Position Falls to 6.87%

HK Disclosure
·
Aug 06

TRANSTHERA-B: Morningside Bio-Ventures Limited Disposes of Shares, Long Position Falls to 6.87%

HK Disclosure
·
Aug 06

TRANSTHERA-B: Ghalibo (PTC) Limited Disposes of Shares, Long Position Falls to 6.87%

HK Disclosure
·
Aug 06

TRANSTHERA-B: Ching Fen Chan Tan Disposes of Shares, Long Position Falls to 6.87%

HK Disclosure
·
Aug 06

TRANSTHERA-B: Genecare Development Limited Disposes of Shares, Long Position Falls to 6.87%

HK Disclosure
·
Aug 06

Movement Alert|TRANSTHERA-B Rises 5.08% in Regular Trading, Intensive Buybacks and Multi-Pipeline Clinical Progress Drive Continued Rebound

Market Focus
·
Aug 06

Movement Alert|TRANSTHERA-B Rises 8.83% in Regular Trading, Innovative Drug Sector Rally Combined with Intensive Share Buybacks

Market Focus
·
Aug 05

Movement Alert|TRANSTHERA-B Rises 18% in Regular Trading, HK Innovative Drug Sector Rallies as Buybacks Signal Management Confidence

Market Focus
·
Aug 04

TransThera Sciences Grants 5.26 Million H-Share Awards and Options to 67 Employees, Including Two Directors

Bulletin Express
·
Jul 24

Transthera-B (02617) Allocates 5.2589 Million H-Shares as Incentive Awards

Stock News
·
Jul 24

TransThera Sciences (Nanjing) Buys Back 217,000 H-Shares for HKD 2.24 Million, Lifting Treasury Stock to 718,000 Shares

Bulletin Express
·
Jul 24

TRANSTHERA-B (02617) Invests HK$1.133 Million in Share Buyback on July 23

Stock News
·
Jul 23

Transthera Sciences Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation

Reuters
·
Jul 23

TransThera-B completes on-market buyback of 105,000 H shares, treasury stock rises to 396,000

Bulletin Express
·
Jul 22

TransThera Sciences buys back 111,000 H-shares, lifts treasury stock to 291,000 units

Bulletin Express
·
Jul 21